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of Left Ventricle Systolic Function in Patient with ST Elevation Myocardial
Infarction
Kabul Priyantoro,1 Daniel Parningotan Tobing1
1Harapan Kita Hospital, Indonesia
BACKGROUND The dynamic of coronary microcirculation post pri-
mary percutaneous coronary intervention (PPCI), which achieves
steady state after 12-48 hours, is inﬂuenced by many factors, one of
them is inﬂammation, and this condition has been correlated with
clinical outcome. The aim of this study was to see the correlation
between total leucocytes count 48 hours post PPCI with short term
improvement of left ventricle (LV) function.
METHODS Of total 103 STEMI subjects whom underwent PPCI, 62
subjects were included completely from Jan to Apr 2013, and followed
until 30 days. Total leucocyte count was measured during admission
and 48 hours post PPCI. Subjects divided in two groups, group with
total leucocyte count 48 hours post PPCI >12,020/uL and group with
total leucocyte count 48 hours post PPCI < 12,020/uL. TIMI ﬂow and
myocardial blush grade were measure immediately post PPCI. LV
systolic function was measured using regional wall motion index
(RWMI) focusing on infarct related artery (IRA) by echocardiography,
soon after PPCI and at 30 days. Intra and inter observer variability
were analyzed. Logistic regression was used to correlate variables
using software Stata ver 12.
RESULTS Patients with total leukocyte count 48 hours post PPCI
>12,020/uL, had OR 4,4 (95% CI:0,98–19,85; p¼0,05) to have irre-
versible segmental LV function in IRA territory at 30 days. Multivar-
iate analysis consistently shown leukocyte post PPCI as strong
predictor of RWMI irreversibility, with OR5,6 (95% CI:1,08–
28,6;p¼0,039).
CONCLUSION High total leukocyte counts 48 hours post PPCI
(> 12,020/uL), can predict irreversible recovery of segmental LV
function in IRA territory at 30 days.
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ST-Segment Elevation in Lead aVR as the Predictive Value in Acute
Coronary Syndromes
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BACKGROUND This study aimed to analyze the prognostic value of
the presence of ST elevation in lead aVR in initial standard electro-
cardiogram (ECG) performed on admission in combination with clin-
ical variables for acute coronary syndromes (ACS).
METHODS In 446 consecutive patients with ACS, we evaluated
admission ECG for aVR and divided patients into two groups: group A
(254 patients with non-ST elevation in aVR) and group B (192 patients
with ST elevation). The clinical and the coronary angiographic data
were compared.
RESULTS 1) There was no signiﬁcant difference in age, gender,
smoking, hypertension, hyperlipidemia and diabetes between two
groups. 2) There were more patients with left main lesion and triple
vessel lesion in group B (24/192 and 36/192) than group A (11/254,31/
254, p value ¼0.01 for left main lesion and 0.055 for triple vessel
lesion). 3) Survival analysis: The death in group A and group B was
28 (11.02%) and 35 (18.23%, p¼0.031), respectively. The overall sur-
vival rate of group A was signiﬁcantly higher than that of group B (log-
rank test, p¼ 0.026, Kaplan-Meier survival cure seen at graph 1). 4)
Cox regression analysis showed that patient mortality hazard in ST
elevation of aVR was 1.745045 folds of patients with non-ST elevation
(p¼0.0275).CONCLUSION ST-segment elevation in lead aVR has a diagnostic and
prognostic value in patients with ACS and may provide an additional
prognostic value to the conventional cardiovascular risk factor.
TCTAP A-127
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BACKGROUND Recent several studies suggest better clinical outcome
of the transradial intervention (TRI) for primary percutaneous coro-
nary intervention (PPCI) for acute ST-segment elevation myocardial
infarction (acute STEMI). The purpose of this study was to determine
whether TRI for acute STEMI is associated with better outcome and
safety compared with transfemoral artery intervention (TFI) in real-
world practice.
METHODS We analyzed 271 consecutive acute STEMI patients (age
63.513.1, 73.4% of male) underwent PPCI in Dongguk University
Gyeongju hospital and the patients with cardiogenic shock were also
included in this study. The number of patients of TRI was 113
(61.613.7 years, 84.1% of male) and TFI was 158 (64.912.4 years,
65.8% of male). We compared between TRI and TFI in terms of death
in 48 hours after admission and bleeding (hemoglobin decreased more
than 4 g/dl and RBC transfusion).
RESULTS There were no differences of catheterization laboratory to
needle time (8.05.3 min vs. 9.25.3 min, p¼0.058) and procedure
success rate (92% vs. 96%, p¼0.114) between TRI group and TFI group.
Mortality in the TRI group and TFI group was 8.0% versus 6.7%
(p¼0.387) at 48 hours after admission and 8.0% versus 11.4%
(p¼0.236) at 30 days. However, the incidence of bleeding was lower in
TRI group than TFI group (0% vs. 7.0%, p¼0.002). In binary logistic
regression analysis, TRI for acute STEMI was not independent pre-
dictor of mortality but left main and triple vessel disease was only
independent predictor for mortality (10.73, 95% CI, 3.78w30.41).
CONCLUSION Our study shows that TRI for acute STEMI did not
reduced mortality at 48 hours and 30 days after admission but
decreased bleeding complications. In experienced operator for both
access sites, the TRI for acute STEMI is the one of the option for
reduction of access site and bleeding complication.
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BACKGROUND Patients with acute coronary syndromes (ACS) un-
dergoing coronary angiography (CAG) or percutaneous coronary
intervention (PCI) are shown to have better outcome. Although the
